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The changing methadone population
Chris Farentinos:The methadone population has
changed. Today we are treating a jobless, skill-less pop-
ulation that is much more difficult to treat than the
patients of decades past. Still, I am not sure I really see
any difference in the effectiveness of methadone today
compared to 10 years ago. I think you have one-third
of people who will benefit, stay on methadone, get
good results, improve their life conditions, get a job.
You have a middle third who will have some relapses
and will struggle, and might diminish the rate of crim-
inal offenses related to drug-seeking. Then you have
the bottom third who cycle through programs.
Doug Ziedonis:The field of addiction has more com-
plicated patients now than in the past, because some
of the easier patients got treatment and moved for-
ward. In the 1980s, when the 28-day programs started,
their success rate was phenomenal, probably because
lots of people got into treatment who should have been
treated as outpatients. The methadone programs that
are left get all the really tough cases: dually diagnosed,
polydrug, polylife problems. Methadone programs
always get all the toughest cases.
Juice alone will work for some people, but not
for tougher cases. So what are you going to do for that
group? How do we strengthen the social treatment in
these different places? Part of it is bringing over mod-
els from other settings, as Brooner and Kidorf 
have done.
What community programs can gain from
the MSC model
Ziedonis: Having behavioral contracts in methadone
treatment isn’t a new thing, even in outpatient set-
tings. The big issue is always, what are the consequences
going to be? Are we going to discharge patients if they
take drugs? Are we going to push them to a high level
of care? Do we have a high level care that they can
go to? Are we going to make them go to more NA
meetings in the community?
Brooner and Kidorf’s paper is good because here
is one program spelling out the way it thinks about
these issues. Some of the smaller programs that
don’t have big psychosocial treatment components
still have behavioral plans, but theirs don’t offer as
many benefits, such as an IOP [intensive outpatient
program] for patients who are doing well as inpatients.
They are more limited on what positive perks there
can be and usually only have negative consequences.
And, from my experience, they usually are not rig-
orous in kicking out people who use drugs.
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Farentinos: The strength of the approach described in
this article is that if you are a patient, your incen-
tives are very strongly connected to attendance and
changing your behavior. Best of all, the model can
be translated to pretty much any other program.
Let me share what we do in an IOP with respect
to punishment versus increased dosage. This is not a
methadone program. One of the things we have found—
and it reflects exactly what the article is saying—is that
if someone is failing in IOP, turning in drug-positive
urines and decreasing attendance, policies are effec-
tive that say, so many missed sessions and you are going
to be bumped up to a more intensive phase, or if you
have a positive urinalysis, you’ll get bumped up to the
more intensive phase. If you produce a drug-free urine
specimen, then you go down again. Having very clear
benchmarks of progress gives the client a measure of
control. It emphasizes the whole idea of motivational
interviewing, in the sense of giving control by laying
out the rules and consequences very clearly. I think
that is very smart.
I met with my IOP people the day after reading
this article, and a number of things came up because
of the article. Many counselors have ideas about
how we can use this structure to make our program
better. At present we have people pay when they miss
sessions, whether they are full-pay clients or even if
they are paying reduced fees. They pay half of the
charge for each session they miss, which is punitive,
but it also encourages them to show up. Now we are
thinking of incorporating an even more structured
way to quantify steps and increase the client’s control
over whether he or she goes forward or backward.
One of the criticisms of voucher programs is the
cost. With this MSC model, you have some imple-
mentation cost, training cost, and design cost, but you
don’t have the actual cost of vouchers. I think the MSC
program design is thought through very well.
Tom Brewster: I am looking forward to presenting this
article to my staff. The discussion will be: What do we
do that is similar to this? How could we modify it to
use some of these ideas?
Frankly, I think we will make some changes.
Specifically, I think we’ll want to quantify our steps
more clearly than we do right now. Currently we make
contingencies that involve take-home privileges, maybe
an increase in counseling sessions, sometimes maybe
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even an adjustment of fees. If you start having posi-
tive urinalyses, your fees will be adjusted upward, so
you’re better off not having positive urinalyses. I think
our contingency system as it stands is a little unsys-
tematic. Using Brooner and Kidorf’s approach would
clarify things for our staff. It would be standardized.
Acceptability of the MSC incentives to com-
munity programs and their patients
Brewster: From a harm-reduction standpoint, in our
program we don’t like to discharge patients for non-
compliance. The risk of discharging patients from
methadone programs is that they will inject drugs,
which makes them vulnerable to HIV, hepatitis, and
other diseases. Of course, if somebody pulls a gun in
a clinic or makes threats, they are discharged. But
for the most part, noncompliance with counseling ses-
sions and what-have-you will not trigger a discharge.
When a person is noncompliant, this article sug-
gests increasing the dose of treatment. I wouldn’t want
a patient to feel antagonism toward the counselor asso-
ciated with the allegedly enhanced, almost punitive-
appearing requirements for additional groups or ses-
sions. I would rather have the clinic set certain rules:
‘Your fee may adjusted; your take-home cycle may be
adjusted. These are clinic rules and they work the same
way for everyone.’
Ziedonis: Sometimes I use a medical model to explain
contingencies to a patient. I say, ‘Look, suppose you
have a broken leg. It could be a simple fracture or a
compound fracture. In addiction, too, there are vari-
ations in the illness. We are going to get to know you
and work with you. We are going to start at this level,
but if a higher level of care is needed, then you will
have to go to a higher level of care.’ It’s framed, not
that ‘you did something wrong and then you get this
consequence,’ but more like ‘we are trying to figure
out the severity of the illness.’
Farentinos: Framing is very important. You can frame
the thought as, ‘You pay half the fee if you don’t show
up, because you did a bad thing.’ Or you can frame it,
‘We really want to see you here. We want to see you
here so much that the incentive for you to be here is
not only that you are moving forward faster and not
being bumped into more intensive levels of care, but
you also don’t have to pay the extra fee.’&